Asciminib 40mg tablets
NHS hospitals in England used £28,845,722 of indicative cost of Asciminib 40mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 43.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Asciminib 40mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Asciminib 40mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Imperial College Healthcare Nhs Trust | £2,479,907 |
| King's College Hpl Nhs Foundation Trust | £1,227,465 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,094,005 |
| University College London Foundation Tr | £1,089,280 |
| East Sussex Healthcare Nhs Trust | £811,424 |
| Mid Yorkshire Hospitals Nhs Trust | £785,097 |
| Western Sussex Hospitals Nhs Found Trust | £780,641 |
| Ruh Bath Nhs Foundation Trust | £672,361 |
| Nottingham University Hospitals Trust | £659,400 |
| The Clatterbridge Cancer Centre Nhs Ft | £644,684 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.